Terveystalo Oy (TTALO) - Net Assets
Based on the latest financial reports, Terveystalo Oy (TTALO) has net assets worth €544.80 Million EUR (≈ $636.93 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.40 Billion ≈ $1.64 Billion USD) and total liabilities (€854.50 Million ≈ $999.00 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Terveystalo Oy to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €544.80 Million |
| % of Total Assets | 38.93% |
| Annual Growth Rate | 9.63% |
| 5-Year Change | -4.08% |
| 10-Year Change | 148.75% |
| Growth Volatility | 28.9 |
Terveystalo Oy - Net Assets Trend (2014–2024)
This chart illustrates how Terveystalo Oy's net assets have evolved over time, based on quarterly financial data. Also explore TTALO total assets for the complete picture of this company's asset base.
Annual Net Assets for Terveystalo Oy (2014–2024)
The table below shows the annual net assets of Terveystalo Oy from 2014 to 2024. For live valuation and market cap data, see Terveystalo Oy (TTALO) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €548.20 Million ≈ $640.90 Million |
+6.36% |
| 2023-12-31 | €515.40 Million ≈ $602.56 Million |
-12.94% |
| 2022-12-31 | €592.00 Million ≈ $692.11 Million |
-2.78% |
| 2021-12-31 | €608.90 Million ≈ $711.87 Million |
+6.54% |
| 2020-12-31 | €571.50 Million ≈ $668.14 Million |
+5.60% |
| 2019-12-31 | €541.20 Million ≈ $632.72 Million |
+5.74% |
| 2018-12-31 | €511.80 Million ≈ $598.35 Million |
+11.92% |
| 2017-12-31 | €457.30 Million ≈ $534.63 Million |
+96.89% |
| 2016-12-31 | €232.27 Million ≈ $271.54 Million |
+5.39% |
| 2015-12-31 | €220.38 Million ≈ $257.65 Million |
+0.87% |
| 2014-12-31 | €218.47 Million ≈ $255.42 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Terveystalo Oy's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 16781100000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €77.90 Million | 14.21% |
| Common Stock | €100.00K | 0.02% |
| Other Comprehensive Income | €485.40 Million | 88.54% |
| Total Equity | €548.20 Million | 100.00% |
Terveystalo Oy Competitors by Market Cap
The table below lists competitors of Terveystalo Oy ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Avino Silver & Gold Mines Ltd
TO:ASM
|
$1.16 Billion |
|
RLJ Lodging Trust
NYSE:RLJ
|
$1.16 Billion |
|
FAWER Automotive Parts Ltd Co
SHE:000030
|
$1.16 Billion |
|
Ningbo Construction Co Ltd
SHG:601789
|
$1.16 Billion |
|
OVH GROUPE UNSP.ADR/1/2
F:7U70
|
$1.16 Billion |
|
Jiangxi Hungpai New Material Co Ltd
SHG:605366
|
$1.16 Billion |
|
Atresmedia Corporación de Medios de Comunicación S.A.
MC:A3M
|
$1.16 Billion |
|
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR
|
$1.16 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Terveystalo Oy's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 515,400,000 to 548,200,000, a change of 32,800,000 (6.4%).
- Net income of 71,700,000 contributed positively to equity growth.
- Dividend payments of 38,000,000 reduced retained earnings.
- Other comprehensive income decreased equity by 2,200,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €71.70 Million | +13.08% |
| Dividends Paid | €38.00 Million | -6.93% |
| Other Comprehensive Income | €-2.20 Million | -0.4% |
| Other Changes | €1.30 Million | +0.24% |
| Total Change | €- | 6.36% |
Book Value vs Market Value Analysis
This analysis compares Terveystalo Oy's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.87x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.08x to 1.87x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | €1.98 | €8.09 | x |
| 2015-12-31 | €1.99 | €8.09 | x |
| 2016-12-31 | €1.99 | €8.09 | x |
| 2017-12-31 | €3.92 | €8.09 | x |
| 2018-12-31 | €4.00 | €8.09 | x |
| 2019-12-31 | €4.25 | €8.09 | x |
| 2020-12-31 | €4.47 | €8.09 | x |
| 2021-12-31 | €4.77 | €8.09 | x |
| 2022-12-31 | €4.66 | €8.09 | x |
| 2023-12-31 | €4.06 | €8.09 | x |
| 2024-12-31 | €4.33 | €8.09 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Terveystalo Oy utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.08%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.35%
- • Asset Turnover: 0.96x
- • Equity Multiplier: 2.55x
- Recent ROE (13.08%) is above the historical average (2.11%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -38.01% | -17.48% | 0.68x | 3.17x | €-104.71 Million |
| 2015 | 0.50% | 0.22% | 0.70x | 3.30x | €-20.82 Million |
| 2016 | 5.44% | 2.30% | 0.75x | 3.17x | €-10.58 Million |
| 2017 | 1.57% | 1.04% | 0.76x | 1.97x | €-38.52 Million |
| 2018 | 13.43% | 9.23% | 0.64x | 2.27x | €17.53 Million |
| 2019 | 10.00% | 5.25% | 0.76x | 2.51x | €-20.00K |
| 2020 | 8.01% | 4.64% | 0.72x | 2.38x | €-11.35 Million |
| 2021 | 13.22% | 6.97% | 0.80x | 2.38x | €19.61 Million |
| 2022 | 4.12% | 1.94% | 0.85x | 2.50x | €-34.80 Million |
| 2023 | -8.19% | -3.28% | 0.91x | 2.75x | €-93.74 Million |
| 2024 | 13.08% | 5.35% | 0.96x | 2.55x | €16.88 Million |
Industry Comparison
This section compares Terveystalo Oy's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $172,600,000
- Average return on equity (ROE) among peers: 21.78%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Terveystalo Oy (TTALO) | €544.80 Million | -38.01% | 1.57x | $1.16 Billion |
| Pihlajalinna Oy (PIHLIS) | $172.60 Million | 21.78% | 2.47x | $244.13 Million |
About Terveystalo Oy
Terveystalo Oyj provides occupational healthcare services in Finland, Sweden, and Estonia. It operates through three segments: Healthcare Services, Portfolio Businesses, and Sweden. The company offers general practice and specialist medical care, diagnostic, outpatient surgery, dental, and other adjacent services; healthcare outsourcing and staffing services; child welfare services; and oral heal… Read more